(BMC pharmacology [electronic resource].[TA])
207 results
  • Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. [Journal Article]
    BMC Pharmacol. 2012 May 29; 12:5.Munro TA, Berry LM, … Cohen BMBP
  • CONCLUSIONS: The negative plasma concentration-effect relationship we observed is difficult to reconcile with simple competitive antagonism, but is consistent with desensitization. The very slow elimination of JDTic from brain is surprising given that it undergoes active efflux, has modest affinity for homogenate, and has a shorter duration of action than nor-BNI under these conditions. We propose that this persistence may result from entrapment in cellular compartments such as lysosomes.
  • Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages. [Journal Article]
    BMC Pharmacol. 2011 Jul 26; 11:8.Palma L, Sfara C, … Magnani MBP
  • CONCLUSIONS: Results reported in this paper show that a 10 nanomolar dose of dexamethasone not only prevents inflammatory activation but is also efficacious in confining active inflammation. This effect is here demonstrated not to occur through "canonical" inhibition of the NF-κB transcription factor but through a distinct cascade of down-modulation, that underlines the importance of the transactivating activity of glucocorticoid receptor in the context of its anti-inflammatory action.